Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acquired coagulation disorders.

C R Prentice

    Clinics in Haematology
    |June 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Coagulation abnormalities can arise from vitamin K deficiency, liver disease, or disseminated intravascular coagulation (DIC). Management involves addressing the underlying cause and careful monitoring of anticoagulant therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cardiogenic thromboembolism: review of clinical trials.

    Platelets·2010
    Same author

    Prevention of fibrinolytic shut-down after major surgery by intramuscular stanozolol.

    Thrombosis research·2010
    Same author

    A European view on the North American fifth consensus on antithrombotic therapy.

    Chest·2000
    Same author

    Thromboprophylaxis--which treatment for which patient?

    The Journal of bone and joint surgery. British volume·2000
    Same author

    Are symptomatic endpoints acceptable in venous thromboprophylactic studies?

    Haemostasis·1999
    Same author

    Transient ischaemic attacks.

    QJM : monthly journal of the Association of Physicians·1999
    Same journal

    Myelodysplastic syndromes.

    Clinics in haematology·1986
    Same journal

    In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.

    Clinics in haematology·1986
    Same journal

    Myelodysplastic syndromes: natural history and features of prognostic importance.

    Clinics in haematology·1986
    Same journal

    Pathogenesis and clinical variations in the myelodysplastic syndromes.

    Clinics in haematology·1986
    Same journal

    The treatment of myelodysplastic syndromes.

    Clinics in haematology·1986
    Same journal

    Secondary myelodysplastic syndromes and leukaemias.

    Clinics in haematology·1986
    See all related articles

    Area of Science:

    • Hematology
    • Internal Medicine
    • Pathophysiology

    Background:

    • Coagulation disorders can develop secondary to various diseases in individuals without prior bleeding issues.
    • Vitamin K deficiency, liver disease, and disseminated intravascular coagulation (DIC) are major causes of acquired hemostatic abnormalities.

    Purpose of the Study:

    • To outline major coagulation abnormalities secondary to diseases.
    • To describe disorders related to vitamin K deficiency, liver disease, and DIC.

    Main Methods:

    • Review of coagulation disorders.
    • Description of vitamin K-dependent clotting factor deficiencies.
    • Tabulation of hemostatic defects in liver disease.
    • Explanation of DIC pathophysiology and associated conditions.

    Related Experiment Videos

    Main Results:

    • Vitamin K deficiency can result from malabsorption, obstructive jaundice, or antibiotic use.
    • Oral anticoagulant use requires careful monitoring due to potential hemorrhage and drug interactions.
    • Liver disease causes hemostatic defects through impaired factor synthesis, vitamin K malabsorption, and DIC.
    • DIC is a complex syndrome involving coagulation activation and fibrinolysis, triggered by various conditions like infections, trauma, and neoplasia.

    Conclusions:

    • Acquired coagulation abnormalities necessitate identification and management of the underlying disease.
    • Effective treatment of DIC involves addressing the initiating condition.
    • Careful patient monitoring is crucial, especially for those on oral anticoagulants.